PDF herunterladen
Thorac Cardiovasc Surg
DOI: 10.1055/a-2447-0020
Original Cardiovascular

Impact of High-intensity Statin on Atrial Fibrillation after Off-Pump Coronary Artery Bypass

Yeiwon Lee
1   Department of Critical Care, Seoul National University Hospital, Jongno-gu, Seoul, Korea
,
Yoonjin Kang
2   Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Jongno-gu, Seoul, Korea
,
Ji Seong Kim
2   Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Jongno-gu, Seoul, Korea
,
Sue Hyun Kim
1   Department of Critical Care, Seoul National University Hospital, Jongno-gu, Seoul, Korea
,
Suk Ho Sohn
2   Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Jongno-gu, Seoul, Korea
,
Ho Young Hwang
1   Department of Critical Care, Seoul National University Hospital, Jongno-gu, Seoul, Korea
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

Background There is uncertainty regarding the impact of high-intensity statins on postoperative outcomes in patients undergoing surgical myocardial revascularization. This study was conducted to evaluate the impact of high-intensity statin treatment on the occurrence rate of new-onset postoperative atrial fibrillation (POAF) after off-pump coronary artery bypass grafting (OPCAB).

Methods Six hundred and thirteen patients (66.8 ± 9.8 years, male:female = 476:137) who underwent isolated OPCAB were retrospectively enrolled. Hypertension (n = 409, 66.7%), diabetes mellitus (n = 343, 59.6%), and chronic kidney disease (n = 138, 22.5%) were common comorbidities. Statins and beta-blockers were administered to all patients until the day of surgery and resumed within 6 hours after surgery. Risk factors associated with POAF were analyzed, including the use of high-intensity statins (atorvastatin 40–80 mg or rosuvastatin 20 mg), as well as baseline characteristics and preoperative risk factors.

Results High-intensity statins were used in 158 patients (25.8%). POAF occurred in 184 patients (30.0%). The use of high-intensity statins was not correlated with preoperative levels of low-density lipoprotein (p = 0.446) or high-sensitivity C-reactive protein (p = 0.478). Multivariate logistic regression analysis revealed that the use of high-intensity statins was significantly associated with a reduced occurrence of POAF (p = 0.022, odds ratio [95% confidence interval] = 0.592 [0.378–0.926]). Age, acute coronary syndrome, insulin-dependent diabetes mellitus, and chronic kidney disease were also significantly associated with POAF.

Conclusion Preoperative administration of high-intensity statins was associated with a 41% reduction in the occurrence rate of POAF in patients who underwent OPCAB.

Keywords

coronary artery bypass grafts surgery - CABG - off-pump surgery - postoperative care - arrhythmia therapy (includes Maze; surgical ablation) - surgery - complications


Publikationsverlauf

Eingereicht: 16. August 2024

Angenommen: 16. Oktober 2024

Accepted Manuscript online:
24. Oktober 2024

Artikel online veröffentlicht:
10. Dezember 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Mathew JP, Parks R, Savino JS. et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 1996; 276 (04) 300-306
    CrossrefPubMedSuche in Google Scholar
  • 2 Sakamoto H, Watanabe Y, Satou M. Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting?. Ann Thorac Cardiovasc Surg 2011; 17 (04) 376-382
    CrossrefPubMedSuche in Google Scholar
  • 3 Miceli A, Fino C, Fiorani B. et al. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2009; 87 (06) 1853-1858
    CrossrefPubMedSuche in Google Scholar
  • 4 Rezk M, Taha A, Nielsen SJ. et al. Clinical course of postoperative atrial fibrillation after cardiac surgery and long-term outcome. Ann Thorac Surg 2022; 114 (06) 2209-2215
    CrossrefPubMedSuche in Google Scholar
  • 5 Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135 (12) 1061-1073
    CrossrefPubMedSuche in Google Scholar
  • 6 Ishii Y, Schuessler RB, Gaynor SL. et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005; 111 (22) 2881-2888
    CrossrefPubMedSuche in Google Scholar
  • 7 Liakopoulos OJ, Dörge H, Schmitto JD, Nagorsnik U, Grabedünkel J, Schoendube FA. Effects of preoperative statin therapy on cytokines after cardiac surgery. Thorac Cardiovasc Surg 2006; 54 (04) 250-254
    Thieme ConnectPubMedSuche in Google Scholar
  • 8 Lertsburapa K, White CM, Kluger J, Faheem O, Hammond J, Coleman CI. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg 2008; 135 (02) 405-411
    CrossrefPubMedSuche in Google Scholar
  • 9 Camm AJ, Kirchhof P, Lip GY. et al; European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31 (19) 2369-2429
    CrossrefPubMedSuche in Google Scholar
  • 10 Marín F, Pascual DA, Roldán V. et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 2006; 97 (01) 55-60
    CrossrefPubMedSuche in Google Scholar
  • 11 Liakopoulos OJ, Kuhn EW, Hellmich M. et al; StaRT-CABG Investigators. Statin loading before coronary artery bypass grafting: a randomized trial. Eur Heart J 2023; 44 (25) 2322-2331
    CrossrefPubMedSuche in Google Scholar
  • 12 Kunt A, Özcan S, Küçüker A, Odabaşi D, Sami Kunt A. Effects of perioperative statin treatment on postoperative atrial fibrillation and cardiac mortality in patients undergoing coronary artery bypass grafting: a propensity score analysis. Med Glas 2015; 12 (02) 190-195
    PubMedSuche in Google Scholar
  • 13 Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 2008; 136 (06) 1541-1548
    CrossrefPubMedSuche in Google Scholar
  • 14 Larmann J, Theilmeier G. Inflammatory response to cardiac surgery: cardiopulmonary bypass versus non-cardiopulmonary bypass surgery. Best Pract Res Clin Anaesthesiol 2004; 18 (03) 425-438
    CrossrefPubMedSuche in Google Scholar
  • 15 Calkins H, Hindricks G, Cappato R. et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017; 14: 275-444
    CrossrefPubMedSuche in Google Scholar
  • 16 Cannon CP, Braunwald E, McCabe CH. et al; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350 (15) 1495-1504
    CrossrefPubMedSuche in Google Scholar
  • 17 Nissen SE, Tuzcu EM, Schoenhagen P. et al; Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352 (01) 29-38
    CrossrefPubMedSuche in Google Scholar
  • 18 Ozaydin M, Dogan A, Varol E. et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2007; 107 (02) 117-121
    CrossrefPubMedSuche in Google Scholar
  • 19 Mariscalco G, Lorusso R, Klersy C. et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 2007; 84 (04) 1158-1164
    CrossrefPubMedSuche in Google Scholar
  • 20 Zheng Z, Jayaram R, Jiang L. et al. Perioperative rosuvastatin in cardiac surgery. N Engl J Med 2016; 374 (18) 1744-1753
    CrossrefPubMedSuche in Google Scholar
  • 21 Hillis LD, Smith PK, Anderson JL. et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2012; 143 (01) 4-34
    CrossrefPubMedSuche in Google Scholar
  • 22 Lawton JS, Tamis-Holland JE, Bangalore S. et al; Writing Committee Members. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022; 79 (02) e21-e129
    CrossrefPubMedSuche in Google Scholar
  • 23 Heames RM, Gill RS, Ohri SK, Hett DA. Off-pump coronary artery surgery. Anaesthesia 2002; 57 (07) 676-685
    CrossrefPubMedSuche in Google Scholar